BACKGROUND:[18F] fluorodeoxyglucose positron emission tomography (FDG-PET)
imaging has been employed as a non-invasive diagnostic tool for malignant tumors. Total …

Purpose To determine whether whole-body total lesion glycolysis (TLG), which combines
volumetric and metabolic information from fluorine 18 fluorodeoxyglucose (FDG) positron …

Aim To assess the feasibility and prognostic value of measuring total lesion glycolysis of the
primary tumour (TLG primary) using combined 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) …

Abstract Background and Aims To determine whether the primary tumor SUVmax and total
lesion glycolysis (TLG) measured on 18F‐FDG PET/CT have prognostic significance in …

Despite the favorable prognosis of stage IA non–small cell lung cancer (NSCLC), the
disease recurs after complete surgical resection in 20%–30% of patients. This study …

Purpose We investigated fluorine-18 fluorodeoxyglucose positron emission
tomography/computed tomography (FDG PET/CT)-assessed metabolic tumor volume (MTV) …

Purpose The objective of this study was to assess the prognostic value of metabolic tumor
burden on 2-deoxy-2-[18 F] fluoro-D-glucose (18 F-FDG) positron emission tomography …

OBJECTIVE: To assess the prognostic value of metabolic tumor burden as measured with
metabolic tumor volume (MTV) and total lesion glycolysis (TLG) on 2-deoxy-2-(18F) fluoro-D …

Purpose This study aimed to evaluate the prognostic value of metabolic tumor burden as
measured with metabolic tumor volume (MTV) and total lesion glycolysis (TLG), as well as …

Purpose To determine whether whole-body metabolic tumor burden, measured as either
metabolic tumor volume (MTV WB) or total lesion glycolysis (TLG WB), using FDG-PET/CT is …